Neothetics Provides Business Update and Reports First Quarter 2017 Financial Results
11 mai 2017 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today provided a...
Neothetics to Provide a Business Update and Release First Quarter 2017 Financial Results Thursday, May 11th, 2017
04 mai 2017 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, May 04, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, announced today...
Neothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset
05 avr. 2017 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, April 05, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today announced the...
Neothetics to Present at the 16th Annual Needham Healthcare Conference
29 mars 2017 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that Susan A. Knudson, Neothetics’ Chief Financial Officer, will present at the 16th Annual Needham...
Neothetics Provides Business Update and Reports Fourth Quarter 2016 Financial Results
23 mars 2017 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, March 23, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update and reported financial results for the fourth quarter 2016. “We are encouraged by our...
Neothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat
20 mars 2017 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, March 20, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today announced...
Neothetics to Provide a Business Update and Release Fourth Quarter 2016 Financial Results Thursday, March 23, 2017
16 mars 2017 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, March 16, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its fourth quarter 2016 financial results before the...
Neothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat
23 déc. 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Dec. 23, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for LIPO-202 for the reduction of...
Neothetics to Provide a Business Update and Release Third Quarter 2016 Financial Results Thursday, November 10, 2016
03 nov. 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its third quarter 2016 financial results before the...
Neothetics Provides Business Update and Reports Second Quarter 2016 Financial Results
11 août 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update on its strategic and operational initiatives and reported financial results for the...